Chemoradiotherapy vs. chemotherapy for locally advanced pancreatic cancer

(The JAMA Network Journals) In a study appearing in the May 3 issue of JAMA, Pascal Hammel, M.D., of Beaujon Hospital, Clichy, France and colleagues assessed whether chemoradiotherapy improves overall survival of patients with locally advanced pancreatic cancer controlled after four months of gemcitabine-based induction chemotherapy, and assessed the effect of erlotinib on survival. Gemcitabine and erlotinib are drugs used to treat cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news